Security key
89455T109
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI)
CUSIP: 89455T109
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common stock, $0.001 par value
- Shares outstanding
- 64,609,137
- Total 13F shares
- 35,847,129
- Share change
- -3,937,660
- Total reported value
- $87,953,121
- Put/Call ratio
- 647%
- Price per share
- $2.45
- Number of holders
- 114
- Value change
- -$21,913,008
- Number of buys
- 56
- Number of sells
- 69
Report period
Q4 2025
Institutions
114
Top holders
10
TMCI full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
TREACE MEDICAL CONCEPTS, INC. SEC filings
TREACE MEDICAL CONCEPTS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 89455T109
Recent filing periods:
Top shareholders of TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
13D/G
|
Company |
9.9%
from 13D/G
|
6,316,000
|
$42,380,360 | — | 30 Sep 2025 | |
| GAGNON SECURITIES LLC |
13D/G
13F
|
Neil Gagnon · Company |
9.6%
|
6,142,107
|
$15,355,268 | +$5,406,632 | 31 Dec 2025 | |
| MORGAN STANLEY |
13D/G
13F
|
Company |
3.4%
|
2,091,809
|
$13,931,448 | $0 | 31 Dec 2024 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
13D/G
|
Company |
1.8%
from 13D/G
|
3,634,381
|
$24,386,697 | — | 30 Sep 2025 | |
| Aaron Berutti |
3/4/5
|
SVP, Sales |
0.32%
|
205,092
|
$1,230,552 | — | 09 Aug 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.6%
|
1,710,140
|
$11,475,039 | — | 30 Sep 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
2.6%
|
1,686,521
|
$11,316,556 | — | 30 Sep 2025 | |
| First Eagle Investment Management, LLC |
13F
|
Company |
1.9%
|
1,238,895
|
$8,312,985 | — | 30 Sep 2025 | |
| Gagnon Advisors, LLC |
13F
|
Company |
1.5%
|
968,464
|
$6,498,393 | — | 30 Sep 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.4%
|
931,818
|
$6,252,499 | — | 30 Sep 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
1.3%
|
847,675
|
$5,687,899 | — | 30 Sep 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.2%
|
761,333
|
$5,108,544 | — | 30 Sep 2025 | |
| Opaleye Management Inc. |
13F
|
Company |
1.1%
|
702,245
|
$4,712,064 | — | 30 Sep 2025 | |
| CenterBook Partners LP |
13F
|
Company |
1%
|
674,370
|
$4,525,023 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.64%
|
415,006
|
$2,784,690 | — | 30 Sep 2025 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.5%
|
493,584
|
$246,693 | — | 30 Sep 2025 | |
| Acuitas Investments, LLC |
13F
|
Company |
0.47%
|
301,100
|
$2,020,381 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.46%
|
452,542
|
$226,180 | — | 30 Sep 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.42%
|
271,937
|
$1,822,000 | — | 30 Sep 2025 | |
| PARADIGM CAPITAL MANAGEMENT INC/NY |
13F
|
Company |
0.39%
|
250,000
|
$1,677,500 | — | 30 Sep 2025 | |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC |
13F
|
Company |
0.39%
|
249,332
|
$1,495,992 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.38%
|
244,464
|
$1,640,406 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.35%
|
224,781
|
$1,508,281 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.33%
|
214,664
|
$1,440,396 | — | 30 Sep 2025 | |
| Arcadia Wealth Management, Inc. |
13F
|
Company |
0.32%
|
209,972
|
$1,408,912 | — | 30 Sep 2025 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.31%
|
203,133
|
$1,363,023 | — | 30 Sep 2025 | |
| UNITED SERVICES AUTOMOBILE ASSOCIATION |
13F
|
Company |
0.31%
|
302,743
|
$151,311 | — | 30 Sep 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.29%
|
188,915
|
$1,267,620 | — | 30 Sep 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.29%
|
186,157
|
$1,249,113 | — | 30 Sep 2025 | |
| Birchview Capital, LP |
13F
|
Company |
0.27%
|
176,947
|
$1,187,314 | — | 30 Sep 2025 | |
| KESTRA PRIVATE WEALTH SERVICES, LLC |
13F
|
Company |
0.23%
|
226,142
|
$113,026 | — | 30 Sep 2025 | |
| MOORE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.23%
|
147,607
|
$990,443 | — | 30 Sep 2025 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.22%
|
142,999
|
$959,523 | — | 30 Sep 2025 | |
| TAKEDA PHARMACEUTICAL CO LTD |
13F
|
Company |
0.21%
|
203,190
|
$101,554 | — | 30 Sep 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.2%
|
129,868
|
$871,414 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.19%
|
122,952
|
$825,009 | — | 30 Sep 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.17%
|
111,278
|
$747,000 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.16%
|
103,205
|
$692,505 | — | 30 Sep 2025 | |
| CWA Asset Management Group, LLC |
13F
|
Company |
0.15%
|
150,000
|
$74,970 | — | 30 Sep 2025 | |
| GABELLI FUNDS LLC |
13F
|
Company |
0.14%
|
88,500
|
$593,835 | — | 30 Sep 2025 | |
| FMR LLC |
13F
|
Company |
0.13%
|
81,787
|
$548,790 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.13%
|
81,587
|
$547,450 | — | 30 Sep 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.12%
|
79,531
|
$533,643 | — | 30 Sep 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.12%
|
113,206
|
$56,000 | — | 30 Sep 2025 | |
| FULLER & THALER ASSET MANAGEMENT, INC. |
13F
|
Company |
0.11%
|
68,900
|
$462,319 | — | 30 Sep 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.1%
|
64,550
|
$433,131 | — | 30 Sep 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.1%
|
63,047
|
$423,045 | — | 30 Sep 2025 | |
| COMERICA BANK |
13F
|
Company |
0.09%
|
55,000
|
$369,050 | — | 30 Sep 2025 | |
| Creative Planning |
13F
|
Company |
0.07%
|
46,110
|
$309,398 | — | 30 Sep 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.07%
|
45,685
|
$306,546 | — | 30 Sep 2025 |
Institutional Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q4 2025
As of 31 Dec 2025,
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) was held by
114 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,847,129 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, BlackRock, Inc., GAGNON SECURITIES LLC, BANK OF AMERICA CORP /DE/, VANGUARD GROUP INC, Gagnon Advisors, LLC, MILLENNIUM MANAGEMENT LLC, CIBC Private Wealth Group LLC, First Eagle Investment Management, LLC, and WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC.
This page lists
114
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
117
Q4 2025 holders
114
Holder diff
-3
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.